Evidence map›Paper›PMID 18596587›Full record

ReviewCurrent opinion in allergy and clinical immunology2008

Understanding the mechanisms of anaphylaxis.

Richard D Peavy, Dean D Metcalfe

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in allergy and clinical immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 2 syntheses or guidelines pooled it, 206 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Emerging Therapies for Anaphylaxis.Immunology and allergy clinics of North America · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Assessment of Patients With Beta-Lactams Positive Provocation Tests by Biomarkers of IgG-Related Neutrophil Activation.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Using the Right Criteria for MCAS.Current allergy and asthma reports · 2024
    Review
  17. Quality of Life in the Management of Anaphylaxis in Food-Allergic Adults.International journal of general medicine · 2024
    Article
  18. Article
  19. Review
  20. Review

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Richard D PeavyLaboratory of Allergic Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-1881, USA. peavyr@niaid.nih.gov
Dean D Metcalfe
National Institute of Allergy and Infectious Diseases · USNational Institutes of Health · US

Funding

The Pathogenesis, Diagnosis, And Treatment Of Systemic Mast Cell DisordersZIAAI000249 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI KOMAROW, HIRSH D · 2009 to 2025
$16.5M
THE PATHOGENESIS, DIAGNOSIS, AND TREATMENT OF SYSTEMIC MAST CELL DISORDERSZ01AI000249 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI METCALFE, DEAN D · 1985 to 2008
$1.7M
Intramural NIH HHS NIH0013412243
6 · The paper itself

Abstract

purpose of reviewThe present review considers recent reports that identify the roles of key intermediate signaling components and mediators during and after mast cell activation and degranulation leading to anaphylaxis. RECENT

findingsMechanisms of anaphylaxis are becoming better understood as the interaction of several regulatory systems in the mast cell activation and degranulation signaling cascade. Multiple tyrosine kinases, activated after immunoglobulin E binding to the high-affinity receptors for immunoglobulin E (FcepsilonRI), exert both positive and negative regulation on the signaling cascade, which may vary with genetic background or mutations in signaling proteins. Calcium influx, the essential, proximal intracellular event leading to mast cell degranulation, is controlled also by both negative and positive regulation through calcium channels. Sphingosine-1-phosphate is emerging as a newly realized mediator of anaphylaxis, acting as a signaling component within the mast cell and as a circulating mediator. SUMMARY: Anaphylaxis is a systemic reaction involving multiple organ systems, but it is believed that it may be influenced by cellular events in mast cells and basophils resulting in the release of mediators. Therefore, understanding the mechanisms of mast cell activation and degranulation is critical to understanding the mechanisms of anaphylaxis. Recent reports have identified important regulatory components of the signaling cascade and, consequently, potential targets for therapeutic intervention.

Indexed as

AnaphylaxisAnimalsCalcium ChannelsCell DegranulationHumansImmunoglobulin EInflammation MediatorsLysophospholipidsMast CellsMastocytosis, SystemicMiceProto-Oncogene Proteins c-fynSignal TransductionSphingosinesrc-Family KinasesCalcium ChannelsFYN protein, humanImmunoglobulin EInflammation Mediatorslyn protein-tyrosine kinaseLysophospholipidsProto-Oncogene Proteins c-fynSphingosinesphingosine 1-phosphatesrc-Family Kinases

Identifiers

PMID18596587
PMCPMC2683407
OpenAlexW2043965664

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.